The Alliance AMBUSH Trial: Rationale and Design
Unlike medulloblastoma (MB) in children, robust prospective trials have not taken place for older patients due to the low incidence of MB in adults and adolescent and young adults (AYA). Current MB treatment paradigms for older patients have been extrapolated from the pediatric experience even thoug...
Main Authors: | Anita Mahajan, Helen Shih, Marta Penas-Prado, Keith Ligon, Kenneth Aldape, Leland S. Hu, Ashlee R. Loughan, Michael R. Basso, Heather E. Leeper, Brian V. Nahed, Shannon L. Stott, Susan Geyer, Caterina Giannini, Evanthia Galanis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/2/414 |
Similar Items
-
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis
by: Yuchen Li, et al.
Published: (2019-07-01) -
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
by: Lidia Gatto, et al.
Published: (2022-01-01) -
Real-Life Experience with Sonidegib for Locally Advanced Basosquamous Carcinoma: A Case Series
by: Enrico Bocchino, et al.
Published: (2024-01-01) -
Molecular and clinical correlates of medulloblastoma subgroups: A narrative review
by: Hallie Coltin, et al.
Published: (2021-01-01) -
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas
by: Keisuke Katsushima, et al.
Published: (2023-03-01)